Skip to main content
Top
Published in: BMC Nephrology 1/2021

Open Access 01-12-2021 | Care | Research

Referring patients with chronic kidney disease back to primary care: a criteria-based analysis in outpatient renal clinics

Authors: Carola van Dipten, Davy Gerda Hermina Antoin van Dam, Wilhelmus Joannes Carolus de Grauw, Marcus Antonius Gerard Jan ten Dam, Marcus Matheus Hendrik Hermans, Willem Jan Jozef Assendelft, Nynke Dorothea Scherpbier-de Haan, Jacobus Franciscus Maria Wetzels

Published in: BMC Nephrology | Issue 1/2021

Login to get access

Abstract

Background

The increased demand for nephrology care for patients with chronic kidney disease (CKD) necessitates a critical review of the need for secondary care facilities and the possibilities for referral back to primary care. This study aimed to evaluate the characteristics and numbers of patients who could potentially be referred back to primary care, using predefined criteria developed by nephrologists and general practitioners.

Method

We organised a consensus meeting with eight nephrologists and two general practitioners to define the back referral (BR) criteria, and performed a retrospective cohort study reviewing records from patients under nephrologist care in three hospitals.

Results

We reached a consensus about the BR criteria. Overall, 78 of the 300 patients (26%) in the outpatient clinics met the BR criteria. The characteristics of the patients who met the BR criteria were: 56.4% male, a median age of 70, an average of 3.0 outpatients visits per year, and a mean estimated glomerular filtration rate of 46 ml/min/1,73m2. Hypertension was present in 67.9% of this group, while 27.3% had diabetes and 16.9% had cancer. The patients who could be referred back represented all CKD stages except stage G5. The most common stage (16%) was G3bA2 (eGFR 30 ≤ 44 and ACR 3 ≤ 30).

Conclusion

A substantial proportion of patients were eligible for referral back to primary care. These patients often have a comorbidity, such as hypertension or diabetes. Future research should focus on generalisability of the BR criteria, the feasibility of actual implementation of the back referral, follow-up assessments of renal function and patient satisfaction.
Literature
2.
go back to reference Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO. Clinical practice guideline for the evaluation and Management of Chronic Kidney Disease. Kidney Inter Suppl. 2012;2013(3):1–150. Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO. Clinical practice guideline for the evaluation and Management of Chronic Kidney Disease. Kidney Inter Suppl. 2012;2013(3):1–150.
3.
go back to reference Nederlands huisartsen genootschap. NHG - Standaard Chronische Nierschade. Huisarts en Wetenschap; 2018. Nederlands huisartsen genootschap. NHG - Standaard Chronische Nierschade. Huisarts en Wetenschap; 2018.
4.
go back to reference NICE Clinical guideline: Chronic kidney disease. Early identification and management of chronic kidney disease in adults in primary and secondary care. London: National Collaborating Centre And National Institute for Health and care Excellence; 2008 September (last modified 2014, July). NICE Clinical guideline: Chronic kidney disease. Early identification and management of chronic kidney disease in adults in primary and secondary care. London: National Collaborating Centre And National Institute for Health and care Excellence; 2008 September (last modified 2014, July).
12.
go back to reference Van Gelder VA, Scherpbier-De Haan ND, De Grauw WJ, Vervoort GM, Van Weel C, Biermans MC, et al. Quality of chronic kidney disease management in primary care: a retrospective study. Scand J Prim Health Care. 2016:1–8. Van Gelder VA, Scherpbier-De Haan ND, De Grauw WJ, Vervoort GM, Van Weel C, Biermans MC, et al. Quality of chronic kidney disease management in primary care: a retrospective study. Scand J Prim Health Care. 2016:1–8.
26.
go back to reference Wilson C, Campbell SM, Luker KA, Caress AL. Referral and management options for patients with chronic kidney disease: perspectives of patients, generalists and specialists. Health Expect. 2015;18(3):325–34. Wilson C, Campbell SM, Luker KA, Caress AL. Referral and management options for patients with chronic kidney disease: perspectives of patients, generalists and specialists. Health Expect. 2015;18(3):325–34.
30.
go back to reference Smekal MD, Tam-Tham H, Finlay J, Donald M, Benterud E, Thomas C, et al. Perceived benefits and challenges of a risk-based approach to multidisciplinary chronic kidney disease care: a qualitative descriptive study. Can J Kidney Health Dis. 2018;5:2054358118763809.CrossRef Smekal MD, Tam-Tham H, Finlay J, Donald M, Benterud E, Thomas C, et al. Perceived benefits and challenges of a risk-based approach to multidisciplinary chronic kidney disease care: a qualitative descriptive study. Can J Kidney Health Dis. 2018;5:2054358118763809.CrossRef
Metadata
Title
Referring patients with chronic kidney disease back to primary care: a criteria-based analysis in outpatient renal clinics
Authors
Carola van Dipten
Davy Gerda Hermina Antoin van Dam
Wilhelmus Joannes Carolus de Grauw
Marcus Antonius Gerard Jan ten Dam
Marcus Matheus Hendrik Hermans
Willem Jan Jozef Assendelft
Nynke Dorothea Scherpbier-de Haan
Jacobus Franciscus Maria Wetzels
Publication date
01-12-2021
Publisher
BioMed Central
Published in
BMC Nephrology / Issue 1/2021
Electronic ISSN: 1471-2369
DOI
https://doi.org/10.1186/s12882-021-02367-1

Other articles of this Issue 1/2021

BMC Nephrology 1/2021 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine